UF at the AACR Annual Meeting 2021

Physicians and researchers from the University of Florida will participate in the virtual American Association for Cancer Research Annual Meeting being held on April 10-15, 2021.

AACR is a premier event in cancer research. The AACR Annual Meeting program covers the latest discoveries across the spectrum of cancer research—from population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy—and highlights the work of the best minds in research and medicine from institutions all over the world. The full conference program is available here.

The online planner displays the sessions, presentations and abstracts for Week 1 of the virtual AACR Annual Meeting, April 10-15, 2021. Session information for Week 2 (May 17-21) will be posted after Week 1 has ended. The names of UF collaborators are bolded below.


Saturday, April 10, 2021

PO.CH01.03 – Drug Delivery
280 – Sub-30-nm capsules for drug delivery
Time: 8:30 a.m. – 11:59 p.m.
Xiaowei Ma, Ping Zhang, Chao Cui, Chang-Chun Ling, Lina Cui.
University of Florida, Gainesville, FL, University of Calgary, Calgary, AB, Canada

PO.CH02.01 – Structural and Chemical Biology
328 – Selective fluorogenic probe for rapid detection of cathepsin L activity
Time: 8:30 a.m. – 11:59 p.m.
Kelton A. Schleyer, Ben Fetrow, Peter Fatland, Jun Liu, Maya Chaaban, Biwu Ma, Lina Cui.
University of Florida, Gainesville, FL, University of New Mexico, Albuquerque, NM, Florida State University, Tallahassee, FL

PO.CH02.01 – Structural and Chemical Biology
329 – Targeting an emerging oncogenic biomarker, heparinase
Time: 8:30 a.m. – 11:59 p.m.
Lina Cui.
University of Florida, Gainesville, FL

PO.CL04.01 – Clinical Research in Racial and Ethnic Minorities and Other Underserved Populations
430 – Perceptions among African Americans of prostate cancer and clinical trials: A focus group study
Time: 8:30 a.m. – 11:59 p.m.
Lourdes A. Baezconde-Garbanati, Carolina Aristizabal, Sandra Suther, Fern Webb, Mariana C. Stern.
USC Norris Comprehensive Cancer Center, Los Angeles, CA, Florida Agricultural and Mechanical University, Tallahassee, FL, University of Florida, Jacksonville, FL

PO.EP01.12 – Next-Generation Sequencing in Epidemiology Studies
862 – Transcriptomics analysis reveals unique immunoinflammatory signatures of nigerian prostate cancer
Time: 8:30 a.m. – 11:59 p.m.
Solomon Oladapo Rotimi, Abidemi E. Omonisi, Faruk Mohammed, Paul Jibrin, Babatunde Duduyemi, Daniel B. Olusina, Yili Xu, Yuxin Jin, Xiyu Liu, Guang Q. Xiao, Folakemi Odedina, John Carpten, Renee Reams, Zarko Manojlovic.
Covenant, Ota, Nigeria, Ekiti State University, Ado Ekiti, Nigeria, Ahmadu Bello University, Zaria, Nigeria, National Hospital, Abuja, Nigeria, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana, University of Nigeria, Enugu, Nigeria, University of Southern California, Los Angeles, CA, University of Florida, Gainesville, Nigeria, Florida A&M University, Tallahassee, FL

PO.EP01.13 – Pathway and Candidate Gene Studies of Risk or Prognosis
869 – Breast tumor gene expression in the mTOR pathway and clinicopathological characteristics in Black women and White women
Time: 8:30 a.m. – 11:59 p.m.
Mmadili N. Ilozumba, Song Yao, Adana A. M. Llanos, Angela Omilian, Weizhou Zhang, Susmita Datta, Chi-Chen Hong, Warren Davis, Thaer Khoury, Christine B. Ambrosone, Ting-Yuan D. Cheng.
University of Florida, Gainesville, FL, Roswell Park Comprehensive Cancer Center, Buffalo, NY, Rutgers School of Public Health, Piscataway, NJ, Roswell Park Comprehensive Cancer Center, Buffalo, NY, University of Florida, Gainesville, FL, University of Florida, Gainesville, FL, Roswell Park Comprehensive Cancer Center, Buffalo, NY

PO.EP01.13 – Pathway and Candidate Gene Studies of Risk or Prognosis
875 – Associations of aspirin and other anti-inflammatory medications with breast cancer risk by the status of COX2 receptor
Time: 8:30 a.m. – 11:59 p.m.
Lusine Na Yaghjyan, Heather Eliassen, Graham Colditz, Bernard Rosner, Akemi Wijayabahu, Rulla Tamimi.
University of Florida, Gainesville, FL, Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, Washington University in St. Louis, St. Louis, MO, Cornell University, New York, NY

PO.EP01.18 – Survivorship Research
905 – Investigating the effects of aerobic exercise on preclinical breast cancer outcomes
Time: 8:30 a.m. – 11:59 p.m.
Zachary Richard WakefieldMai TanakaAngela Bundy, Sharon Lepler, Christine Pampo, Lori Rice, Dietmar W. Siemann.
University of Florida, Gainesville, FL, University of Florida, Gainesville, FL

PO.ET01.05 – New Targets
1228 – Novel small molecule inhibitors that target the exportin binding pocket of TOP2A for the treatment of multiple myeloma
Time: 8:30 a.m. – 11:59 p.m.
Joel G. TurnerDavid Ostrov, Nicholas Lawrence, Jana Dawson, Juan Gomez, Alexis Bauer, Mark Meads, Alex Achille, Kenneth Shain.
Moffitt Cancer Center, Tampa, FL, University of Florida, Gainesville, FL

PO.ET03.01 – Drug Resistance in Molecular Targeted Therapies
1116 – HDAC8 activity regulates stress induced phenotype switching in melanoma
Time: 8:30 a.m. – 11:59 p.m.
Michael Emmons, Richard Bennett III, Alberto Riva, Bin Fang, Edward Seto, John Koomen, Jonathan Licht, Keiran Smalley.
Moffitt Cancer Center, Tampa, FL, University of Florida, Gainesville, FL, George Washington University, Washington DC, DC

PO.ET06.07 – Tyrosine Kinase and Phosphatase Inhibitors
1477 – Co-targeting c-Met and c-Src pathways to inhibit metastatic cancer cell migration and invasion
Time: 8:30 a.m. – 11:59 p.m.
Yao Dai, Dietmar W. Siemann.
University of Florida, Gainesville, FL

PO.MCB01.01 – Cell Signaling
1975 – Tumor treating fields triggers OFD1 removal from primary cilia to promote glioma cell survival
Time: 8:30 a.m. – 11:59 p.m.
Ping Shi, Jia Tian, Matthew R. Sarkisian.
University of Florida, Gainesville, FL

PO.MCB03.07 – Tumor Suppressor Genes
2499 – SerpinA6 and itspotential role in prostate cancer progression.
Time: 8:30 a.m. – 11:59 p.m.
Ilaha Isali, Jatinder Kumar, Nishka Shukla, Ahmad Khalifa, Sanjeev Shukla.
Case Western Reserve University, Cleveland, OH, University of Florida, Jacksonville, FL, Case Western Reserve University, Cleveland, OH

PO.MCB05.01 – Epigenetics
2112 – Epigenetic control of heparanase expression using CRISPR/dCas9
Time: 8:30 a.m. – 11:59 p.m.
Zixin Chen, Guihua Zeng, Xiaogang Li, Fu-Sen Liang, Lina Cui.
University of Florida, Gainesville, FL, University of New Mexico, Albuquerque, NM

PO.MCB05.01 – Epigenetics
2117 – Immunomodulatory functions of SMYD3 in HPV-negative head and neck squamous cell carcinoma
Time: 8:30 a.m. – 11:59 p.m.
Nupur Nigam, Benjamin Jonah Bernard, Kyunghee Burkitt, Sohyoung Kim, Yvette Robbins, Richard L. BennettJonathan D. Licht, Vassiliki Saloura.
NCI, National Institutes of Health, Bethesda, MD, LRBGE, NCI, National Institutes of Health, Bethesda, MD, NIDCD, National Institutes of Health, Bethesda, MD, University of Florida Health Cancer Center, Gainesville, FL

PO.PR02.01 – Clinical Prevention, Early Detection, and Interception
2531 – Function-related indicator and outcomes of screening mammography in older women from the BCSC-Medicare Cohort
Time: 8:30 a.m. – 11:59 p.m.
Dongyu Zhang, Linn Abraham, Joshua Demb, Diana L. Miglioretti, Shailesh Advani, Brian L. Sprague, Louise M. Henderson, Tracy Onega, Karen Wernli, Louise C. Walter, Karla Kerlikowske, John T. Schousboe, Ellen S. O’Meara, Dejana Braithwaite.
University of Florida, Gainesville, FL, Kaiser Permanente Washington Health Research Institute, Seattle, WA, University of California, San Diego, La Jolla, CA, University of California, Davis, Davis, CA, Georgetown University, Washington, DC, University of Vermont College of Medicine, Burlington, VT, University of North Carolina at Chapel Hill, Chapel Hill, NC, University of Utah, Salt Lake City, UT, University of California, San Francisco, San Francisco, San Francisco, CA, University of Minnesota, Minneapolis, MN

PO.PR02.01 – Clinical Prevention, Early Detection, and Interception
2535 – Leukemic Cell Proteomic Profiling in Pediatric AML
Time: 8:30 a.m. – 11:59 p.m.
Nam K. Nguyen, Huiyun Wu, Junmin Peng, Jeffrey E. Rubnitz, Stanley Pounds, Jatinder K. Lamba.
University of Florida College of Pharmacy, Gainesville, FL, St. Jude Children’s Research Hospital, Memphis, TN, St. Jude Children’s Research Hospital, Memphis, TN, St. Jude Children’s Research Hospital, Memphis, TN

PO.TB06.02 – Tumor Microenvironment
3154 – Host and neoplastic cell Axl inhibition impair prostate and breast cancer bone metastasis
Time: 8:30 a.m. – 11:59 p.m.
Mai Tanaka, Dietmar W. Siemann.
University of Florida, Gainesville, FL

MS.MCB01.01 – Cell Growth Signaling Pathways
82 – Identification of essential proliferation and trametinib resistance mechanisms in GNAQ-mutant uveal melanoma
Time: 5:04 – 5:15 p.m.
Richard L. Bennett, Darby C. Monagle, Amin Sobh, Christopher Vakoc, Keiran S. M. Smalley, J William Harbour, Jonathan D. Licht.
University of Florida Health Cancer Center, Gainesville, FL, University of Florida, Gainesville, FL, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, Bascom Palmer Eye Institute and Sylvester Cancer Center, Miami, FL

Monday, April 12, 2021

Session FO08 – Microbiome Pandemonium: Checkpoints and the Microbiome
Taking a deep dive into intestinal bacteriome signature associated with immune checkpoint inhibitors’ responses
Time: 4:30 – 4:40 p.m.
Christian Jobin.
Univ. of Florida, Gainesville, FL